Form 4 for NTRA Natera, Inc.
Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-20 · accession 0001415889-24-030182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-26 | 2024-12-20 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +4,719 | 116.4K | +4% | — |
| M | 2024-12-26 | 2024-12-23 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.60 | -2,428 | 119.4K | -2% | -$387.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-20 | A | A | 3,044 | — | 119,425 | D | — | — | (F3) On August 30, 2024, the Reporting Person was granted RSUs covering 3,044 shares of Common Stock which vest upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On December 20, 2024, the criteria was satisfied for the vesting of RSUs covering 3,044 shares of Common Stock. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Common | Common Stock | 2024-12-20 | A | A | 1,675 | — | 116,381 | D | — | — | (F1) On October 22, 2021, the Reporting Person was granted Restricted Stock Units ("RSUs") covering 10,000 shares of Common Stock which vest in tranches upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On December 20, 2024, the criteria was satisfied for the vesting of RSUs covering 1,675 shares of Common Stock. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 3 | Common | Common Stock | 2024-12-23 | S | D | 2,423 | $159.60 | 116,997 | D | — | — | (F4) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021 and August 30, 2024, respectively. |
| 4 | Common | Common Stock | 2024-12-23 | S | D | 2 | $158.06 | 119,423 | D | — | — | (F4) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021 and August 30, 2024, respectively. |
| 5 | Common | Common Stock | 2024-12-23 | S | D | 3 | $158.19 | 119,420 | D | — | — | (F4) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021 and August 30, 2024, respectively. |